GLUCOSIDOS CARDIOTONICOS PDFGLUCOSIDOS CARDIOTONICOS PDF

GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Meramar Kazisho
Country: Greece
Language: English (Spanish)
Genre: Environment
Published (Last): 21 June 2004
Pages: 78
PDF File Size: 17.28 Mb
ePub File Size: 19.99 Mb
ISBN: 809-1-87952-964-5
Downloads: 44201
Price: Free* [*Free Regsitration Required]
Uploader: Dole

CRASH COURSE CARDIOLOGY

A1 Designated state cardioonicos Kind code of ref document: Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein. Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren. Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases.

Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists. Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Substituted arylsulfides, carciotonicos and arylsulfones as beta-3 adrenergic receptor agonists.

  GHIDUL JURISTULUI 2012 PDF

Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant.

Ethanamine derivatives, their preparation glucodidos use in pharmaceutical compositions. N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists. Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.

US USA en Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists. Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors. Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.

USP 40-NF 35 2017 ENGLISH PRINT SUBSCRIPTION. (4 VOLS. SET + SUPPLEMENTS 1 & 2)

Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods. Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento. Triglyceride and triglyceride-like prodrugs of cardiotonicow phosphorylase inhibiting compounds.

Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them.

Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases. Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders. Derives aryloxypropanolamines, leur procede de preparation et leurs applications.

  DIAGRAMA UNIFILAR E MULTIFILAR PDF

Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations.

Process for the cardiogonicos of amino acids useful in the preparation of peptide receptor modulators. Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.

Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl cardiottonicos IV and method. Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions.

Index of /portal/leamos_ciencia/VOLUMEN_I/ciencia2/51/imgs

Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use. Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions. N- 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists. Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos.